A decrease in plasma levels of C14:0 ceramide was associated with changes in insulin-stimulated glucose disposal (r = −0.56; P < 0.01) in adult subjects with obesity or type 2 diabetes (T2D). This evidence concerns the gene INS and type 2 diabetes mellitus.